|
Research Management and Support
|
RMS ES 2017
|
$326,124,631
|
$21,000
|
N/A
|
National Institutes of Health
|
|
0021.0001 CG 425 METAVIVOR
|
261200800001E
|
$319,219,481
|
$4,498
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
AIDS Malignancy Consortium (AMC)
|
5UM1CA121947-11
|
$22,965,613
|
$5,741,403
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Cancer Center Support Grant
|
5P30CA015704-42
|
$9,559,285
|
$95,593
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-41
|
$7,810,244
|
$156,205
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
Cancer Center Support Grant
|
5P30CA016086-41
|
$7,114,974
|
$284,599
|
EARP, HENRY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Regional Oncology Research Center
|
2P30CA006973-54
|
$7,060,038
|
$70,600
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
5P30CA014089-42
|
$6,263,488
|
$939,523
|
Wayne, Alan
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Cancer Center Support Grant
|
5P30CA047904-29
|
$5,129,654
|
$102,593
|
FERRIS, ROBERT
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
5P30CA060553-23
|
$4,865,652
|
$48,657
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Cancer Center Support Grant
|
5P30CA016042-42
|
$4,295,192
|
$343,615
|
TEITELL, MICHAEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$4,201,344
|
$210,067
|
Bilusic, Marijo
|
CCR (NCI)
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-11
|
$3,253,119
|
$32,531
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-48
|
$2,645,581
|
$52,912
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
OHSU Knight Cancer Institute
|
2P30CA069533-19
|
$2,310,000
|
$161,700
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Development of a Vaccine for HIV-AIDS: Humoral Immunity
|
ZIA BC 011058
|
$1,984,075
|
$595,223
|
Robert-Guroff, Marjorie
|
CCR (NCI)
|
|
Herpesviral Oncogenesis, Latency and Reactivation
|
5P01CA019014-38
|
$1,812,080
|
$1,014,765
|
DAMANIA, BLOSSOM
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Innate Immune Responses and Vaccines Against Tumor-Associated Herpesviruses
|
5P01CA177322-04
|
$1,778,661
|
$1,778,661
|
SUN, REN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Early Events in KSVH Infection of Primary B-cells
|
5P01CA174439-05
|
$1,571,505
|
$785,753
|
ROBERTSON, ERLE
|
UNIVERSITY OF PENNSYLVANIA
|
|
Molecular Diagnostics Core Laboratory
|
ZIC BC 011079
|
$1,554,465
|
$77,723
|
Raffeld, Mark
|
CCR (NCI)
|
|
DNA Vaccines
|
ZIA BC 010749
|
$1,507,952
|
$753,976
|
Pavlakis, George
|
CCR (NCI)
|
|
KSHV Persistence and Pathogenesis
|
5P01CA180779-05
|
$1,472,214
|
$736,107
|
JUNG, JAE
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Noncoding RNAs in gamma-Herpesvirus Biology and AIDS Malignancies
|
1P01CA214091-01
|
$1,356,357
|
$244,144
|
RENNE, ROLF
|
UNIVERSITY OF FLORIDA
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,094,457
|
$21,889
|
Barr, Frederic
|
CCR (NCI)
|
|
Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses
|
ZIA SC 010357
|
$1,000,515
|
$200,103
|
Zheng, Zhi-Ming
|
CCR (NCI)
|
|
Molecular Basis of KSHV oncogenesis
|
5R35CA200422-02
|
$958,770
|
$958,770
|
JUNG, JAE
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
CD206 Targeted Therapy for Kaposi Sarcoma and Tumor Associated Macrophages
|
4R44CA206788-02
|
$939,552
|
$939,552
|
COPE, FREDERICK
|
NAVIDEA BIOPHARMACEUTICALS, INC.
|
|
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies
|
ZIA BC 010885
|
$924,476
|
$277,343
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Discovery and Characterization of New Human Cancer Viruses
|
5R35CA197463-02
|
$922,575
|
$461,288
|
MOORE, PATRICK
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Addressing Herpesvirus-associated Cancers through the UNC-Malawi Cancer Consortiu
|
5U54CA190152-04
|
$875,813
|
$472,939
|
GOPAL, SATISH
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Receptor Mediated SPECT Imaging Of Kaposi Sarcoma With 99mTc-Tilmanocept
|
5R44CA192859-03
|
$866,508
|
$866,508
|
COPE, FREDERICK
|
NAVIDEA BIOPHARMACEUTICALS, INC.
|
|
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
|
ZIA BC 010791
|
$842,389
|
$168,478
|
Carrington, Mary
|
CCR (NCI)
|
|
Rhesus HHV-8 homologue in AIDS-related malignancies
|
5R01CA075922-21
|
$794,238
|
$794,238
|
WONG, SCOTT
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
UM CFAR SCCC Argentina Consortium for research and training in Virally Induced AIDS Malignancies
|
1U54CA221208-01
|
$731,876
|
$263,475
|
MESRI, ENRIQUE
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Biologic Determinants of the Natural History of AIDS-Defining Cancers in Uganda
|
5U54CA190146-04
|
$688,290
|
$337,262
|
PHIPPS, WARREN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Research International Training and Intervention Consortium (CRITIC)
|
5U54CA190155-04
|
$680,763
|
$211,037
|
WOOD, CHARLES
|
UNIVERSITY OF NEBRASKA LINCOLN
|
|
The Zambia AIDS Malignancies Diagnosis and Pathogenesis Program (ZAMDAPP)
|
1U54CA221204-01
|
$670,280
|
$341,843
|
WOOD, CHARLES
|
UNIVERSITY OF NEBRASKA LINCOLN
|
|
(PQ5) Effect of HIV infection on viral and host gene expression and antitumor immunity in Kaposi Sarcoma in Africa
|
1R01CA217138-01
|
$644,421
|
$644,421
|
WARREN, EDUS
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Clinical Trials of Patients with AIDS-Related Malignancies
|
ZIA BC 010888
|
$621,630
|
$186,489
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$587,732
|
$58,773
|
Gottesman, Michael
|
CCR (NCI)
|
|
Biostatistics and Data Management Section
|
ZID SC 007202
|
$578,591
|
$28,930
|
Steinberg, Seth
|
CCR (NCI)
|
|
Functions of KSHV microRNAs
|
ZIA BC 011176
|
$574,853
|
$287,427
|
Ziegelbauer, Joseph
|
CCR (NCI)
|
|
Development of a Vaccine for HIV-AIDS: Cellular Immunity
|
ZIA BC 011062
|
$566,879
|
$187,070
|
Robert-Guroff, Marjorie
|
CCR (NCI)
|
|
Early Stage Diagnosis of Kaposi's Sarcoma in Limited Resource Settings using KS-Detect
|
5UH2CA202723-02
|
$498,956
|
$498,956
|
ERICKSON, DAVID
|
CORNELL UNIVERSITY
|
|
Interplay Between KSHV and PDGFRA in AIDS-Kaposi's Sarcoma Oncogenesis
|
5R01CA136387-08
|
$457,223
|
$457,223
|
MESRI, ENRIQUE
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Genetic and Biochemical Studies of KSHV LANA
|
5R01CA082036-18
|
$421,563
|
$421,563
|
KAYE, KENNETH
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cell model for KSHV infection and genetic manipulation
|
2R01CA096512-10A1
|
$412,500
|
$412,500
|
GAO, SHOU-JIANG
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Development of a Small Molecule Inhibitor for KSHV LANA
|
5R01CA186775-04
|
$394,250
|
$394,250
|
LIEBERMAN, PAUL
|
WISTAR INSTITUTE
|
|
Heme oxygenase-1 as a tumor factor and therapeutic target for Kaposi sarcoma
|
5R01CA179921-03
|
$393,725
|
$393,725
|
MOSES, ASHLEE
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Mechanism of KSHV-induced angiogenesis
|
5R01CA132637-09
|
$391,875
|
$391,875
|
GAO, SHOU-JIANG
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
Total relevant funding to Kaposi Sarcoma for this search: $31,195,995
|